Abstract # 2238 A Phase I Trial of Samarium-153-Lexidronam with Hormonal Therapy and Radiation Therapy for High-risk, Clinically Non-metastatic Prostate Cancer

Presenter: Valicenti, Richard

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

R. Valicenti*, E. Trabulsi*, C. Intenzo*, J. Lavarino*, Y. Xu*, I. Chervoneva*. , Thomas Jefferson University, Philadelphia, PA,

Author Disclosure:
R. Valicenti, Berlex Inc., B. Research Grant; E. Trabulsi, None; C. Intenzo, None; J. Lavarino, None; Y. Xu, None; I. Chervoneva, None.

E-mail a friend about this abstract:
Enter email address:   

Abstracts Main Page | Logout